In this renewal application, the overall objective of this established and successful multidisciplinary training program in Digestive Diseases continues to be to train qualified postdoctoral individuals (M.D., and/or Ph.D.) for academic careers in gastroenterology and hepatology. The grant includes 33 Full Faculty (a net increase of 3 faculty since the last renewal) from both clinical and basic science departments with two tracks for potential trainees: i) basic/disease oriented research;and ii) patient-oriented research. The basic/disease oriented research tract remains one of long-standing excellence with training opportunities in cell biology, cancer biology, neuromuscular sciences, and experimental surgery/transplantion [sic] research. Training in this track is strongly supported through interactions with the NIH funded Mayo Comprehensive Cancer Center and Departments of Biochemistry/Molecular Biology, Pharmacology, Immunology, and Physiology. The patient-oriented research tract, which has seen recent expansion, maintains training opportunities in epidemiology/outcomes, human trials, and also a new initiative that encompasses Obesity and Nutrition. Training in this track is strongly buttressed by a recently awarded NIH Clinical Translational Science Award to Mayo Clinic. New R01 funded faculty have been added in all the tracks;especially those with an emphasis on Pediatrics or Nutrition. We continue to request support for 5 postdoctoral trainees per year that are selected through objective and consensus-driven mechanisms from a very large and talented pool of M.D., PhD, or M.D./PhD candidates derived from a variety of clinical and basic disciplines. The overall success of the program continues to be outstanding with 70% of former trainees over the last 10 years maintaining staff appointments within academic medicine and a funding portfolio from this cohort that includes 7 new NIH grants. Our aggressive recruitment of both female and underrepresented minority candidates also continues, with 44 % of the candidates deriving from female or minority groups during the last 10 years. This approach is strengthened by increased faculty representation of females and underrepresented minorities. Thus, this well established training program remains nimble and innovative, thereby continuing to be highly successful in achieving its goal of training individuals for academic careers in gastroenterology and hepatology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007198-36
Application #
8010168
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
1979-01-01
Project End
2013-12-31
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
36
Fiscal Year
2011
Total Cost
$291,053
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra et al. (2016) A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma. J Biol Chem 291:8031-47
Lalia, Antigoni Z; Dasari, Surendra; Johnson, Matthew L et al. (2016) Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans. J Clin Endocrinol Metab 101:626-34
Cao, H; Eppinga, R D; Razidlo, G L et al. (2016) Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process. Oncogene 35:1099-110
Tabibian, James H; Yang, Ju Dong; Baron, Todd H et al. (2016) Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. Dig Dis Sci 61:53-61
Johnson, Matthew L; Distelmaier, Klaus; Lanza, Ian R et al. (2016) Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults. Diabetes 65:74-84
Rizvi, Sumera; Borad, Mitesh J (2016) The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine? J Gastrointest Oncol 7:789-796
Hirsova, Petra; Ibrahim, Samar H; Verma, Vikas K et al. (2016) Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology 64:2219-2233
Yang, Ju Dong; Campion, Michael B; Liu, Minetta C et al. (2016) Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma. Hepatology 63:148-58
Johnson, Matthew L; Irving, Brian A; Lanza, Ian R et al. (2015) Differential Effect of Endurance Training on Mitochondrial Protein Damage, Degradation, and Acetylation in the Context of Aging. J Gerontol A Biol Sci Med Sci 70:1386-93
Hickey, Raymond D; Mao, Shennen A; Amiot, Bruce et al. (2015) Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transpl 21:442-53

Showing the most recent 10 out of 138 publications